Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a behind-the-scenes update; no study information or visible content is altered.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the study record, indicating a new release of the page. This typically reflects minor edits or corrections to the record without changing the study details.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site's software revision was updated from v3.6.0 to v3.6.2, signaling a minor platform update. This likely reflects backend improvements or bug fixes without altering the public study details shown on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and an explicit recruitment status line ('No longer looking for participants'), and standardizes the Intervention/Treatment label while updating the page revision tag to v3.6.0.SummaryDifference0.5%

- Check59 days agoChange DetectedThe revision stamp on the page was updated from v3.5.4 to v3.5.5, signaling a new release of the page framework. No study details or visible content were changed.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous Revision: v3.5.3, indicating a minor update to the study record on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.